-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 J+z2lW1CPJYCyL6Cn+/mID85myYVPnC9MRi/3bj3k922y9aw2U601jWY5TlJ1jcC
 WHE6iLnx03cxyMTKtKS5Zw==

<SEC-DOCUMENT>0001181431-11-006297.txt : 20110201
<SEC-HEADER>0001181431-11-006297.hdr.sgml : 20110201
<ACCEPTANCE-DATETIME>20110201161631
ACCESSION NUMBER:		0001181431-11-006297
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20110131
FILED AS OF DATE:		20110201
DATE AS OF CHANGE:		20110201

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Ellman Herman
		CENTRAL INDEX KEY:			0001374177

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-53772
		FILM NUMBER:		11563354

	MAIL ADDRESS:	
		STREET 1:		C/O WARNER CHILCOTT HOLDINGS CO., LTD.
		STREET 2:		100 ENTERPRISE DRIVE
		CITY:			ROCKAWAY
		STATE:			NJ
		ZIP:			07866

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Warner Chilcott plc
		CENTRAL INDEX KEY:			0001323854
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				980626948
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1 GRAND CANAL SQUARE
		CITY:			DOCKLANDS, DUBLIN 2, IRELAND
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		353 1 897 2000

	MAIL ADDRESS:	
		STREET 1:		1 GRAND CANAL SQUARE
		CITY:			DOCKLANDS, DUBLIN 2, IRELAND
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Warner Chilcott Ltd
		DATE OF NAME CHANGE:	20060914

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Warner Chilcott Holdings Co Ltd
		DATE OF NAME CHANGE:	20050414
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rrd298143.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2011-01-31</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001323854</issuerCik>
        <issuerName>Warner Chilcott plc</issuerName>
        <issuerTradingSymbol>WCRX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001374177</rptOwnerCik>
            <rptOwnerName>Ellman Herman</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O WARNER CHILCOTT CORPORATION</rptOwnerStreet1>
            <rptOwnerStreet2>100 ENTERPRISE DRIVE</rptOwnerStreet2>
            <rptOwnerCity>ROCKAWAY</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>07866</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Senior V.P., Clinical Devel.</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Ordinary shares, par value $0.01 per share</value>
            </securityTitle>
            <transactionDate>
                <value>2011-01-31</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>572</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>23.3495</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>227153</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <remarks>The above disclosed sales were made pursuant to an existing 10b5-1 plan to cover taxes associated with the vesting of restricted shares.</remarks>

    <ownerSignature>
        <signatureName>/s/ Herman Ellman</signatureName>
        <signatureDate>2011-02-01</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----